Patented emulsified Oil of Oregano in sustained release form. Biotics Research Corporation is widely recognised for its emulsified fat-soluble nutrients and other lipids, microemulsified with the practical objective of increased absorption and bioavailability. This technology has now been applied to the oil of oregano. By emulsifying oregano extracts, the effective surface area of the oil is dramatically increased.
An additional step was to apply a sustained release mechanism to A.D.P., assuring a slow release throughout the digestive tract. The combined effect of emulsification and sustained release is to enhance intestinal exposure to the essential oil.
Unwelcome guests in the human gastrointestinal tract are more common and have a much greater negative impact on health than is commonly recognised. These bugs range from bacteria and yeasts to parasites and amoebas, hence the need to address these imbalances with anti-microbial agents. Nature contains many different anti-microbials and oregano oil extract, containing the active ingredient of carvacrol, is one of these. It has a broad range of action addressing many different species including B. Hominis but the list includes and is not limited to: Listeria monocytogenes, Giardia lamblia, Staphylococcus aureus, Escherichia coli O:157:H7, Yersinia enterocolitica, Pseudomonas aeruginosa, Aspergillus niger, Geotrichum (yeast), Rhodotorula (yeast), Entamoeba hartmanni, Entamoeba histolytica, Endolimax nana.
PATENT ISSUED
The patent has been issued (#5,955,086) for the "eradication of intestinal parasites and amoebas in humans.